MedPath

SINCLAIR PHARMACEUTICALS LIMITED

🇫🇷France
Ownership
-
Employees
-
Market Cap
-
Website

A Study to Evaluate the Safety and Effectiveness of Injectable Gel for Correction of Infraorbital Hollowing in Chinese Population

Not Applicable
Recruiting
Conditions
Infraorbital Hollowing
Interventions
Device: Cross-linked sodium hyaluronate gel for injection containing lidocaine
First Posted Date
2024-05-01
Last Posted Date
2024-05-01
Lead Sponsor
Sinclair Pharmaceuticals Limited
Target Recruit Count
172
Registration Number
NCT06394076
Locations
🇨🇳

Peking University Third Hospital, Beijing, Beijing, China

A Clinical Trial to Evaluate the Efficacy and Safety of LANLUMA V to Improve Jawline Contour Deficit

Not Applicable
Not yet recruiting
Conditions
Jawline Contour Deficit
Interventions
Device: Poly-L-lactin Acid (PLLA) Based Facial Injectable
First Posted Date
2024-04-30
Last Posted Date
2024-04-30
Lead Sponsor
Sinclair Pharmaceuticals Limited
Target Recruit Count
192
Registration Number
NCT06391580
Locations
🇨🇳

Beijing Hospital, Beijing, Beijing, China

© Copyright 2025. All Rights Reserved by MedPath